Dr A True Ott PhD - Medimmune's "Child FluMist Nasal Spray" Spread H1N1 Swine Flu (2009)

Description from 2009: In 2002, Wyeth (formerly AHP) announced a joint venture with MedImmune Inc to produce an Influenza Vaccine called "FluMist", which is unique in the fact that it is a nasal spray vaccine utilizing live virus. This joint venture dissolved in 2003 thanks to slumping sales, yet MedImmune's FluMist product "has potential" if a pandemic influenza vaccine is needed. This would be especially true if MedImmune could patent the very virus utilized in its nasal spray product.
MedImmune's corporate offices and research labs are located in Gaithersberg, MD, just down the road from the U.S. Institute of Pathology lab at Ft. Detrick, MD where Dr Jeffrey Taubenberger successfully reverse-engineered the deadly 1918 "recombinant" pandemic virus. Shortly after finishing the "resurrection" project, Taubenberger leaves the employ of Ft. Detrick and goes to work for the National Institutes of Health's "National Institute of Allergy and Infectious Diseases." (NIAID).

We see that AHP changed its corporate name to Wyeth in 2002. We also know that AHP, doing business as "Genetics Institute" was heavily involved in the Ft. Detrick "genetic engineering" of viruses at Ft. Detrick, Maryland under the direction of Terrence Tumpey and Jeffrey Taubenberger during the span of years 1998-2002. From its website, we know that Wyeth: "Employs 1,800 and is one of the largest biopharmaceutical operations in the US, housing 7 manufacturing sites and 21 bioreactors, further cementing the claim that Boston is the world's premier biotech corridor". This is important to understand, because a "bio-reactor" is a "particle accelerator" by which cellular gene splicing and mutation by computer-generated design can actually take place on a massive scale. This Harvard-based campus is one of the few places on the planet where a "reverse-engineered" weaponized virus could be massively produced for commercial or military applications.

Could this be why the State of Massachusetts is currently leading the charge to "forced pandemic flu vaccinations" - recommending jail sentences and $1,000 per day fines for those who dare to refuse the vaccine? During this same time frame MedImmune files for patent protection on the genetically altered and reverse-engineered pandemic influenza virus in 2007, the patent is granted, and MedImmune then assigns the patent to MedImmune Vaccines Inc. and to Dr J Taubenberger's National Institutes of Health. This patent is vital in protecting MedImmune's use of the engineered live virus in its FLuMist product.

FluMist is the vaccine of choice for use in schools and young children.